Cargando…
Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
Gastric cancer (GC) is one of the most common malignant neoplasms and is the third leading cause of cancer-related death around the world. Metformin has been well reported to have an inhibitory effect on the growth of various cancers by regulating the expression of microRNAs (miRNAs). However, the s...
Autores principales: | Chen, Yongyi, Gong, Wangang, Zhou, Yun, Fan, Runping, Wu, Yuchen, Pei, Wangwei, Sun, Sufang, Xu, Xiaohong, Jiang, Huifen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798445/ https://www.ncbi.nlm.nih.gov/pubmed/35117650 http://dx.doi.org/10.21037/tcr.2020.03.25 |
Ejemplares similares
-
Erratum to metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
por: Chen, Yongyi, et al.
Publicado: (2020) -
Pleiotropic functions of miR107 in cancer networks
por: Luo, Zhiying, et al.
Publicado: (2018) -
miR-107 regulates tumor progression by targeting NF1 in gastric cancer
por: Wang, Shizhi, et al.
Publicado: (2016) -
The Role of miR-103 and miR-107 in Regulation of CDK5R1 Expression and in Cellular Migration
por: Moncini, Silvia, et al.
Publicado: (2011) -
Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human
por: Parvaee, Pegah, et al.
Publicado: (2019)